Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05658068 · ClinicalTrials.gov registry record · NA

Systems Aligning for Equity (SAFE) Spaces

A NA study of Suicide and Mental Health, sponsored by New York University.

Completed
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT05658068: Completed NA study of Suicide and Mental Health, sponsored by New York University.

NCT05658068 is a NA study of Suicide and Mental Health that has completed, run by New York University. The registered enrollment target is 1,000 participants, below the 6,979-participant average among 92 other Suicide trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05658068, a NA study of Suicide and Mental Health, has completed, sponsored by New York University.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

The goal of this 2-arm cluster randomized clinical trial is to test whether an evidence-based staff training and coaching model specifically designed as a response to legal system-involved youths' and frontline staff's mental health needs can improve the safety and suicide outcomes, mental health challenges, and wellness and facility climate for youth and staff in facilities assigned to the intervention condition. Staff in facilities assigned to the intervention are eligible to receive evidence-based programming in suicide detection and prevention (Shield of Care; SOC) and wellness skill-building (Skills for Life) through training and personalized coaching. Multiple training sessions will be offered to small groups of staff in-person in residential facilities and paired with personalized in-person and virtual coaching. Staff and youth in all facilities will be asked to complete periodic surveys assessing experiences in the facility, suicide and safety knowledge and risk, and their mental health and wellness. Researchers will compare outcomes of staff in youth in facilities assigned to the intervention compared to facilities in the training-as-usual condition.

Primary Outcome

Change in suicide ideation, thoughts, and behaviors

Interventions

  • BEHAVIORAL SAFE Spaces training and coaching

Study Locations (1)

New York

  • New York University - New York

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2022-04-23
Est. Completion 2025-06-30
Phase NA
New York University

83 total trials

What the finished NCT05658068 record still lists

NCT05658068 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 6,979-participant average among 92 other Suicide trials with a reported enrollment target (86% lower).

The record links to 5 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which SAFE Spaces training and coaching is the first listed.

NCT05658068 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05658068 about?

NCT05658068 is a clinical study titled "Systems Aligning for Equity (SAFE) Spaces". The goal of this 2-arm cluster randomized clinical trial is to test whether an evidence-based staff training and coaching model specifically designed as a response to legal system-involved youths' and frontline staff's mental health needs can improve the safety and suicide outcomes, mental health ch...

What is the current status of trial NCT05658068?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-04-23. Estimated completion is 2025-06-30.

What conditions does trial NCT05658068 study?

This clinical trial studies the following conditions: Suicide, Mental Health, Burnout, Professional, Mental Disorder, Self Harm.

What interventions are being tested in trial NCT05658068?

The interventions under investigation include: SAFE Spaces training and coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT05658068?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05658068 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05658068's enrollment target sits among peer trials

1,000 12th of 92 higher than 80 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05658068, the US trial registry maintained by the National Library of Medicine. NCT05658068 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.